Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis

被引:0
|
作者
George W. Reed
Robert A. Gerber
Ying Shan
Liza Takiya
Kimberly J. Dandreo
David Gruben
Joel Kremer
Gene Wallenstein
机构
[1] Corrona Research Foundation,
[2] University of Massachusetts Medical School,undefined
[3] Pfizer Inc,undefined
[4] Corrona,undefined
[5] LLC,undefined
[6] Pfizer Inc,undefined
[7] Albany Medical College,undefined
来源
关键词
Anti-TNF; DMARDs (synthetic); Rheumatoid arthritis; Tofacitinib;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:573 / 586
页数:13
相关论文
共 50 条
  • [41] Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register
    Vieira-Sousa, Elsa
    Eusebio, Monica
    Avila-Ribeiro, Pedro
    Khmelinskii, Nikita
    Cruz-Machado, Rita
    Rocha, Teresa Martins
    Bernardes, Miguel
    Santos-Faria, Daniela
    Silva, Joana Leite
    Santos, Helena
    Miguel, Claudia
    Carvalho, Pedro
    Costa, Tiago
    Duarte, Ana Catarina
    Meirinhos, Tiago
    Nero, Patricia
    Fonseca, Joao Eurico
    Santos, Maria Jose
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (05) : 690 - 700
  • [42] Inhibitors of tumor necrosis factor: New treatment options for rheumatoid arthritis
    Moreland, LW
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 1999, 66 (06) : 367 - 374
  • [43] DIRECT COMPARISON OF EFFECTIVENESS AND SAFETY OF TOFACITINIB AND BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL-WORLD SETTINGS
    Iwamoto, N.
    Suzuki, T.
    Okada, A.
    Fujikawa, K.
    Aramaki, T.
    Mizokami, A.
    Ueki, Y.
    Kawakami, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 581 - 581
  • [44] Comparative Effectiveness of Tocilizumab in Combination with Methotrexate versus Tumor Necrosis Factor Inhibitors (TNFis) in Combination with Methotrexate in Patients with Rheumatoid Arthritis with Prior Exposure to TNFis
    Pappas, Dimitrios
    Blachley, Taylor
    Zlotnick, Steve
    Best, Jennie
    Emeanuru, Kelechi
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [45] COMPARATIVE EFFECTIVENESS OF TOCILIZUMAB IN COMBINATION WITH METHOTREXATE VERSUS TUMOR NECROSIS FACTOR INHIBITORS (TNFIS) IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH PRIOR EXPOSURE TO TNFIS
    Pappas, D. A.
    Blachley, T.
    Zlotnick, S.
    Best, J. H.
    Emeanuru, K.
    Kremer, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 989 - 989
  • [46] Comparative safety of Janus kinase inhibitors and tumor necrosis factor inhibitors in patients undergoing treatment for rheumatoid arthritis
    Fang, Yao-Fan
    Liu, Jia-Rou
    Chang, Shu-Hao
    Kuo, Chang-Fu
    See, Lai-Chu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (11) : 1254 - 1262
  • [47] Comparative Safety of Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Patients Undergoing Treatment for Rheumatoid Arthritis
    Fang, Yao-Fan
    See, Lai-Chu
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2744 - 2747
  • [48] Combination Therapy With Tumor Necrosis Factor Inhibitors in Psoriasis Treatment
    Famenini, Shannon
    Wu, Jashin J.
    CUTIS, 2013, 92 (03): : 140 - 147
  • [49] Real-World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First-Line Tumor Necrosis Factor Inhibitor Therapy in the United States
    Edgerton, Colin
    Frick, Andrew
    Helfgott, Simon
    Huston, Kent Kwas
    Singh, Jasvinder A.
    Zueger, Patrick
    Anyanwu, Samuel I.
    Patel, Pankaj
    Soloman, Nehad
    ACR OPEN RHEUMATOLOGY, 2024, 6 (04) : 179 - 188
  • [50] Real-world Persistence of Initial Targeted Therapy Strategy in Monotherapy versus Combination Therapy in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Sanchez-Piedra, Carlos
    Exposito, Lorena
    Vela, Paloma
    Moreno Ramos, Manuel Jose
    Campos, Cristina
    Bohorquez, Cristina
    Calvo, Jerusalem
    Plaza, Zulema
    Dominguez, Marta
    Diaz-Gonzalez, Jose Federico
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4272 - 4275